GlaxoSmithKline agrees to pay up to $2.2 billion to resolve approximately 80000 lawsuits related to the heartburn drug Zantac
增恶呀渐失
发表于 2024-10-10 12:15:52
1177
0
0
According to Interface News, GlaxoSmithKline announced on October 9th that it has reached agreements with 10 plaintiff companies, representing a total of 93% (approximately 80000 cases) of the pending lawsuit against GlaxoSmithKline's heartburn drug Zantac in state courts in the United States. According to these agreements, GlaxoSmithKline will pay a total of up to $2.2 billion to resolve these cases. The agreement is expected to be fully implemented by the end of the first half of 2025, and the terms of the agreement will be kept confidential. GlaxoSmithKline did not acknowledge any responsibility in the principle agreement of the settlement.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Sanofi lipid-lowering drug Zhilida approved in China
- Musk responded to "drug use" by conducting a three-year randomized drug test in accordance with NASA's requirements
- Weight loss pills will bring benefits again! FDA assessment: Wegovy and other drugs are not associated with suicidal thoughts
- Nearly 800 drugs in the United States collectively raise prices. Novo Nordisk's "weight loss miracle drug" has risen by 3.5%
- Lilly plans to launch the obesity drug Telposide in India as early as next year
- Merck focuses on the development of next-generation cardiac metabolic drugs and competes with oral weight loss therapies
- Apple's new patent explores the future of Vision Pro headset: relieving pain for people with disabilities and helping them reduce drug dependence
- GlaxoSmithKline agrees to pay up to $2.2 billion to resolve approximately 80000 lawsuits related to the heartburn drug Zantac
